Table 3.
Between- and within-group comparisons of adipocytokine.
| Examination (E1) | Examination (E2) | Examination (E3) | Examination (E4) | |
|---|---|---|---|---|
| SPARC (μg/mL) | ||||
| GDM | 1.23 (0.07) | 1.09 (0.06)a | 1.08 (0.06) | 1.03 (0.07)a |
| NGDM | 1.37 (0.05) | 1.11(0.05)a | 1.06 (0.05) | 1.00 (0.05)a |
| p value | 0.11 | 0.80 | 0.80 | 0.68 |
| AFABP (ng/mL) | ||||
| GDM | 9.11 ± 0.69 | 13.57 ± 1.13a | 12.47 ± 1.19a,b | 10.87 (1.00)b |
| NGDM | 7.25 ± 0.52 | 12.28 ± 0.91a | 10.39 ± 0.79a,b | 8.94 ± (0.68)a,b |
| p value | 0.04 | 0.39 | 0.15 | 0.12 |
| Chemerin (ng/mL) | ||||
| GDM | 8.70 (0.46) | 8.17 (0.38) | 7.76 (0.32) | 6.18 (0.35)a,c |
| NGDM | 10.12 (0.35) | 8.14 (0.34)a | 7.74 (0.33)a | 5.79 (0.25)a,b,c |
| p value | 0.02 | 0.94 | 0.97 | 0.40 |
a p value < 0.05 compared to Examination 1. bp value < 0.05 compared to Examination 2. cp value < 0.05 compared to Examination 3. ∗p value < 0.05 compared to NGDM.